US 8367734
Stable epinephrine suspension formulation with high inhalation delivery efficiency
granted A61KA61K31/137A61K9/008
Quick answer
US patent 8367734 (Stable epinephrine suspension formulation with high inhalation delivery efficiency) held by Amphastar Pharmaceuticals, Inc. expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Amphastar Pharmaceuticals, Inc.
- Grant date
- Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/137, A61K9/008